News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
40 Under 40
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
40 Under 40
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
645,144 Results
Type
Article (61286)
Company Profile (69)
Press Release (583789)
Multimedia
Podcasts (59)
Webinars (13)
Section
Business (173734)
Career Advice (2729)
Deals (32437)
Drug Delivery (97)
Drug Development (76902)
Employer Resources (150)
FDA (14939)
Job Trends (13890)
News (304996)
Policy (28952)
Tag
Academia (2893)
Academic (2)
Accelerated approval (6)
Adcomms (22)
Allergies (88)
Alliances (43201)
ALS (88)
Alzheimer's disease (1321)
Antibody-drug conjugate (ADC) (110)
Approvals (14954)
Artificial intelligence (266)
Autoimmune disease (24)
Automation (15)
Bankruptcy (290)
Best Places to Work (10858)
BIOSECURE Act (16)
Biosimilars (101)
Biotechnology (51)
Bladder cancer (78)
Brain cancer (27)
Breast cancer (274)
Cancer (2193)
Cardiovascular disease (165)
Career advice (2312)
Career pathing (33)
CAR-T (155)
Cell therapy (432)
Cervical cancer (20)
Clinical research (62544)
Collaboration (790)
Company closure (1)
Compensation (332)
Complete response letters (20)
COVID-19 (2571)
CRISPR (43)
C-suite (261)
Cystic fibrosis (100)
Data (2166)
Decentralized trials (2)
Denatured (25)
Depression (43)
Diabetes (253)
Diagnostics (6153)
Digital health (19)
Diversity (9)
Diversity, equity & inclusion (39)
Drug discovery (113)
Drug pricing (97)
Drug shortages (23)
Duchenne muscular dystrophy (86)
Earnings (60121)
Editorial (39)
Employer branding (18)
Employer resources (132)
Events (94423)
Executive appointments (768)
FDA (16207)
Fibrodysplasia Ossificans Progressiva (1)
Friedreich's ataxia (4)
Frontotemporal dementia (7)
Funding (749)
Gene editing (110)
Generative AI (20)
Gene therapy (300)
GLP-1 (666)
Government (4458)
Grass and pollen (6)
Guidances (72)
Healthcare (18207)
Huntington's disease (19)
IgA nephropathy (25)
Immunology and inflammation (108)
Indications (28)
Infectious disease (2704)
Inflammatory bowel disease (136)
Inflation Reduction Act (8)
Influenza (53)
Intellectual property (96)
Interviews (526)
IPO (14790)
IRA (38)
Job creations (3416)
Job search strategy (1941)
Kidney cancer (10)
Labor market (30)
Layoffs (505)
Leadership (22)
Legal (6439)
Liver cancer (70)
Lung cancer (304)
Lymphoma (145)
Machine learning (7)
Management (53)
Manufacturing (278)
MASH (64)
Medical device (12659)
Medtech (12664)
Mergers & acquisitions (18225)
Metabolic disorders (635)
Multiple sclerosis (77)
NASH (13)
Neurodegenerative disease (84)
Neuropsychiatric disorders (26)
Neuroscience (1838)
NextGen: Class of 2025 (6382)
Non-profit (4318)
Now hiring (12)
Obesity (322)
Opinion (232)
Ovarian cancer (72)
Pain (92)
Pancreatic cancer (81)
Parkinson's disease (141)
Partnered (21)
Patents (235)
Patient recruitment (112)
Peanut (50)
People (59568)
Pharmaceutical (20)
Pharmacy benefit managers (15)
Phase I (19686)
Phase II (27597)
Phase III (20147)
Pipeline (1151)
Policy (126)
Postmarket research (2473)
Preclinical (8412)
Press Release (67)
Prostate cancer (108)
Psychedelics (27)
Radiopharmaceuticals (251)
Rare diseases (360)
Real estate (5989)
Recruiting (61)
Regulatory (20113)
Reports (33)
Research institute (2397)
Resumes & cover letters (405)
Rett syndrome (5)
RNA editing (3)
RSV (35)
Schizophrenia (68)
Series A (131)
Series B (86)
Service/supplier (9)
Sickle cell disease (51)
Special edition (10)
Spinal muscular atrophy (146)
Sponsored (29)
Startups (3343)
State (1)
Stomach cancer (9)
Supply chain (54)
Tariffs (27)
The Weekly (32)
Vaccines (664)
Venture capitalists (34)
Weight loss (202)
Women's health (30)
Worklife (19)
Date
Today (125)
Last 7 days (848)
Last 30 days (2427)
Last 365 days (30466)
2025 (10280)
2024 (32278)
2023 (36340)
2022 (46625)
2021 (51582)
2020 (50727)
2019 (44783)
2018 (34062)
2017 (30737)
2016 (30076)
2015 (35472)
2014 (28406)
2013 (24976)
2012 (26227)
2011 (26476)
2010 (24975)
Location
Africa (871)
Alabama (54)
Alaska (6)
Arizona (171)
Arkansas (14)
Asia (38322)
Australia (7371)
California (5588)
Canada (1860)
China (487)
Colorado (248)
Connecticut (259)
Delaware (140)
Europe (88579)
Florida (852)
Georgia (200)
Idaho (56)
Illinois (550)
India (25)
Indiana (281)
Iowa (10)
Japan (156)
Kansas (95)
Kentucky (24)
Louisiana (10)
Maine (61)
Maryland (832)
Massachusetts (4034)
Michigan (223)
Minnesota (339)
Mississippi (2)
Missouri (87)
Montana (29)
Nebraska (23)
Nevada (57)
New Hampshire (61)
New Jersey (1650)
New Mexico (29)
New York (1642)
North Carolina (959)
North Dakota (9)
Northern California (2422)
Ohio (195)
Oklahoma (15)
Oregon (36)
Pennsylvania (1236)
Puerto Rico (12)
Rhode Island (31)
South America (1176)
South Carolina (17)
South Dakota (1)
Southern California (2140)
Tennessee (96)
Texas (853)
United States (21342)
Utah (175)
Virginia (143)
Washington D.C. (51)
Washington State (512)
West Virginia (3)
Wisconsin (60)
645,144 Results for "university of melbourne".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Colossal Foundation Donates $1.5M USD to the University of Melbourne to Support Avian Conservation
November 20, 2024
·
5 min read
Press Releases
Transverse Medical Inc. Announces Completion of First Series of Patients in Feasibility Clinical Study at Victorian Heart Hospital, Melbourne, Australia, Using Point-Guard Cerebral Embolic Protection.
April 21, 2025
·
4 min read
Business
David F. Melbourne Jr. Promoted to Chief Executive Officer of AquaBounty; Sylvia Wulf to Continue as Non-Executive Board Chair
The Board of Directors of AquaBounty Technologies, Inc. (NASDAQ: AQB) (“AquaBounty” or the “Company”), a land-based aquaculture company utilizing technology to enhance productivity and sustainability
June 7, 2024
·
8 min read
ONO Enters into a University-Wide, Research Alliance Agreement with Harvard University
Ono Pharmaceutical Co., Ltd. announced that it entered into a five-year, university-wide strategic research alliance agreement with Harvard University aiming at validating novel therapeutic targets.
March 11, 2024
·
3 min read
Lone Star Bio
Colossal Biosciences’ Thylacine Gene-Editing Technologies Provide Hope for Australia’s Endangered Northern Quoll
Scientists from Colossal Biosciences, the world’s first de-extinction company, and the University of Melbourne announce a major step forward in the effort to save Australia’s endangered northern quoll from the invasive cane toad.
May 8, 2024
·
9 min read
Colossal and U Melbourne Hope to Make Thylacine Lore Reality with CRISPR
Working to undo the sins of the past, Colossal Biosciences and the University of Melbourne are attempting to bring back the Tasmanian tiger in a project that could have big implications for human health.
November 3, 2022
·
5 min read
·
Abbey Glasure
Propanc Biopharma Targets Site of First-In-Human Study for PRP at the Peter Mac Cancer Center, Melbourne, Australia
Propanc Biopharma, Inc. today announced that the Company will target the Peter Mac Cancer Center in Melbourne, Australia, as the site for the First-In-Human (FIH) study for PRP in patients with advanced solid tumors.
August 15, 2023
·
5 min read
Press Releases
ENA Respiratory Partners with University of Maryland and Leading Respiratory Disease Expert to Conduct Phase 2 Study of INNA-051 Antiviral Host Defence Enhancer
April 9, 2025
·
4 min read
Layoffs
Astellas Cuts 24 Universal Cells Roles in Seattle, Transfers 12 to Japan
Astellas is opening a second location of Universal Cells, its wholly owned subsidiary, at a research campus in Japan and transferring 12 roles from Universal’s Seattle location.
October 10, 2024
·
1 min read
·
Angela Gabriel
Pharm Country
PCI Pharma Services Announces New Sterile Fill-Finish Capabilities Now Available in Melbourne and San Diego
PCI Pharma Services, a leading global contract development and manufacturing organization, announced that three new state-of-the-art automated sterile fill-finish machines at its San Diego and Melbourne facilities are now fully operational.
April 18, 2023
·
4 min read
1 of 64,515
Next
